共 82 条
- [1] Gross-Jendroska M(1998)Treatment of pigment epithelial detachments due to age-related macular degeneration with intra-ocular C3F8 injection Aust N Z J Ophthalmol 26 311-317
- [2] Flaxel CJ(2004)Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration Arch Ophthalmol 122 453-459
- [3] Schwartz SD(2005)Intravitreal triamcinolone in the treatment of serous pigment epithelial detachment and occult choroidal neovascularization secondary to age-related macular degeneration Eur J Ophthalmol 15 415-419
- [4] Axer-Seigel R(2012)Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF trap, ranibizumab and bevacizumab Angiogenesis 15 171-185
- [5] Ehrlich R(2012)Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 2537-2548
- [6] Rosenblatt I(2008)Predicted biological activity of intravitreal VEGF trap Br J Ophthalmol 92 667-668
- [7] Nicolo M(2011)Prognostic implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization Retina 31 1812-1818
- [8] Ghiglione D(2012)Two-year course of subfoveal pigment epithelial detachment in eyes with age related macular degeneration and visual acuity better than 20/40 Ophthalmologica 228 102-109
- [9] Lai S(2017)Ranibizumab for vascularized pigment epithelial detachment: 1-year anatomic and functional results Graefes Arch Clin Exp Ophthalmol 255 743-751
- [10] Calabria G(2011)One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration Eye 25 1034-1038